Awais led a deep dive into the clinical use and metabolic effects of GLP-1 peptides, covering key pathways: insulin, glucagon, AMPK, GLUT4, leptin, and cortisol. With Leandro, Donna, and Tiffany, the group discussed dosing, side effects like slowed gastric emptying, and microdosing versus standard protocols. Beyond weight loss, lipids, and inflammation, the focus was integrative, personalized care: nutrition, exercise, hormones, and emotional factors. Follow-up on protocols and dosing is coming.